Pharma and Biotech
| £250,000 Convertible Loan Note Issue | 05-Nov-2025 | 07:01 | RNS |
| LOI with leading UK Clinical Diagnostic Group | 05-Nov-2025 | 07:00 | RNS |
| Change of Registered Office | 27-Oct-2025 | 11:32 | RNS |
| Interim Results | 30-Sep-2025 | 07:00 | RNS |
| Update on Clinical Laboratory Partnerships in USA | 29-Sep-2025 | 07:00 | RNS |
| Commercial Progress in USA | 18-Aug-2025 | 07:00 | RNS |
| Result of AGM | 30-Jun-2025 | 13:45 | RNS |
| Notice of AGM | 06-Jun-2025 | 11:00 | RNS |
| Holding(s) in Company | 28-May-2025 | 07:00 | RNS |
| £150,000 Convertible Loan Note Issue | 20-May-2025 | 07:00 | RNS |
| Final results for the year ended 31 December 2024 | 30-Apr-2025 | 11:18 | RNS |
| Contract in Caribbean and Update on CIZ1B | 28-Apr-2025 | 07:00 | RNS |
| Appointment of Non-Executive Director | 25-Mar-2025 | 07:00 | RNS |
| Update on Launch of CIZ1B Biomarker Assay | 24-Mar-2025 | 07:00 | RNS |
| Appointment of Professor Dawn Coverley as CSO | 02-Jan-2025 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 1.63p |
| Change Today | 0.033p |
| % Change | 2.08 % |
| 52 Week High | 2.35 |
| 52 Week Low | 1.29 |
| Volume | 154,481 |
| Shares Issued | 396.39m |
| Market Cap | £6.47m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 12:20 | 70,000 @ 1.67p |
| 11:47 | 81,871 @ 1.53p |
| 09:34 | 234 @ 1.70p |
| 08:13 | 2,376 @ 1.68p |
| Finance Director | Nigel Ronald Lee |
You are here: research